The impact of different prostate-specific antigen (PSA) testing intervals on Gleason score at diagnosis and the risk of experiencing false-positive biopsy recommendations: a population-based cohort study

OBJECTIVE: Given a man’s current prostate- specific antigen (PSA) level, age and family history of prostate cancer, what are the benefits (decreased risk of higher Gleason score [GS] cancer at diagnosis) and harms (increased risk of false-positive biopsy recommendation) of waiting 1, 2, 3, 4 or 5–8 ...

Descripción completa

Detalles Bibliográficos
Autores principales: Palsdottir, Thorgerdur, Nordstrom, Tobias, Karlsson, Andreas, Grönberg, Henrik, Clements, Mark, Eklund, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475177/
https://www.ncbi.nlm.nih.gov/pubmed/30928965
http://dx.doi.org/10.1136/bmjopen-2018-027958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475177/
https://www.ncbi.nlm.nih.gov/pubmed/30928965
http://dx.doi.org/10.1136/bmjopen-2018-027958

Ejemplares similares